Stock Doctor

About the Author Stock Doctor

I am an individual investor who has been actively involved in the healthcare and biotechnology space for over 15 years. I hold a PhD in the biomedical sciences and have worked in both large pharmaceutical and small biotech companies. I make investments based on the fundamentals of a company and if I believe they have a superior technology or products compared to the competition. I'm an investor who believes patience pays off.

Tokai Pharmaceuticals Inc: The Small Cap Biotech With The Billion Dollar Prostate Cancer Drug

  Those that follow my biotech recommendations know that I look for undervalued small cap stocks with significant upside. Some may be momentum …

Medivation Inc (MDVN)’s Price Targets To Increase Based On Xtandi’s Impressive Breast Cancer Efficacy

  I generally advise investors which small cap biotech stocks are worth a look. Medivation Inc (NASDAQ:MDVN) was a small cap stock when …

MEI Pharma Inc (MEIP): Moving Pracinostat Into Phase 3 as Data in Elderly AML Continues to Impress

I stumbled upon MEI Pharma Inc (NASDAQ:MEIP) after reading over the American Society of Hematology (ASH) abstracts at the end of last year. …

Actinium Pharmaceuticals Inc (ATNM)’s Bone Marrow Transplantation Drug Iomab-B Offers Goldmine For Investors

  I’m always hunting for small-cap biotech stocks with under-appreciated drug pipelines or technology that target high unmet medical needs. Sure, I also …

Mature Pipeline Makes Cytokinetics, Inc. The Biggest Bargain In Biotech (CYTK)

  I’ve written about Cytokinetics, Inc. (NASDAQ:CYTK), a biopharmaceutical company that is the industry leader in developing drugs that modulate muscle function, a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts